Thomas K. Equels is CEO & President at HEMISPHERX BIOPHARMA INC (HEB). They have made 27 open-market trades across 2 companies since 2015, most recently 2021-11-24.
27 open-market purchases totalling $841K since 2015, never a sale. Across 25 scored buys the stock is down 13.9% at ninety days, and 16.5 points behind the S&P over the same stretch.
27 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 22% | 19% | 12% |
| Avg Move | -5.6% | -6.6% | -13.9% |
| Alpha | -5.8% | -7.9% | -16.5% |
| Scored | 27 | 27 | 25 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AIM | BUY | 2021-07-16 | 2021-07-16 | $1.92 | $30K | +0.5% | +0.5% | -2.5% |
| AIM | BUY | 2021-02-24 | 2021-02-24 | $2.26 | $25K | -18.6% | -12.1% | -17.4% |
| AIM | BUY | 2020-12-17 | 2020-12-17 | $1.72 | $25K | -4.1% | +7.7% | +23.6% |
| AIM | BUY | 2020-09-03 | 2020-09-03 | $2.03 | $25K | +5.9% | +20.4% | -4.3% |
| AIM | BUY | 2020-08-21 | 2020-08-21 | $2.33 | $25K | -13.6% | -13.2% | -16.6% |
| HEB | BUY | 2019-06-27 | 2019-06-27 | $4.37 | $12K | -9.6% | -37.7% | N/A |
| HEB | BUY | 2019-06-21 | 2019-06-25 | $4.03 | $237K | -10.6% | -37.6% | N/A |
| HEB | BUY | 2019-03-19 | 2019-03-19 | $0.18 | $2K | -6.9% | -15.8% | -36.5% |
| HEB | BUY | 2018-11-30 | 2018-12-03 | $0.19 | $4K | -0.4% | -3.2% | -4.7% |
| HEB | BUY | 2018-10-26 | 2018-10-29 | $0.20 | $700 | +18.8% | -7.5% | +10.4% |
| HEB | BUY | 2018-10-25 | 2018-10-25 | $0.20 | $20K | +9.8% | -2.4% | +8.3% |
| HEB | BUY | 2018-07-27 | 2018-07-27 | $0.29 | $10K | -2.6% | -9.2% | -34.0% |
| HEB | BUY | 2018-07-23 | 2018-07-23 | $0.31 | $35K | -3.4% | -17.2% | -31.9% |
| HEB | BUY | 2018-04-27 | 2018-04-30 | $0.32 | $10K | -5.1% | -5.3% | -6.7% |
| HEB | BUY | 2017-04-27 | 2017-04-27 | $0.69 | $100K | -4.5% | -14.9% | -33.6% |
| HEB | BUY | 2017-04-11 | 2017-04-11 | $0.50 | $100K | +0.1% | -12.1% | -25.7% |
| HEB | BUY | 2016-12-22 | 2016-12-23 | $0.73 | $50K | -1.3% | -12.7% | -31.2% |
| HEB | BUY | 2016-11-01 | 2016-11-01 | $1.00 | $10K | -1.1% | -10.8% | -28.3% |
| HEB | BUY | 2016-07-08 | 2016-07-08 | $0.12 | $6K | +6.1% | +46.6% | -20.1% |
| HEB | BUY | 2016-06-29 | 2016-07-01 | $0.12 | $14K | +0.0% | +8.2% | -13.9% |
| HEB | BUY | 2016-03-18 | 2016-03-21 | $0.13 | $4K | -19.3% | -8.9% | -20.0% |
| HEB | BUY | 2016-03-11 | 2016-03-14 | $0.16 | $6K | -18.8% | -15.1% | -26.8% |
| HEB | BUY | 2016-03-10 | 2016-03-14 | $0.16 | $5K | -18.8% | -15.1% | -26.8% |
| HEB | BUY | 2015-08-13 | 2015-08-14 | $0.18 | $14K | -13.3% | -2.5% | -2.5% |
| HEB | BUY | 2015-04-27 | 2015-04-28 | $0.24 | $24K | -13.3% | -2.5% | -2.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.